CleveX Inc., a promising start-up that has created a device to make it easier to do skin biopsies, has received the second half of $1.7 million promised late last year by investors during the company’s Series B funding round. Investors wanted to break their commitment into two equal tranches “to make sure the company continued […]
Biopsy device company CleveX got a slow start to its product launch. But it since hired a new chief executive officer to, in his words, "turbo-charge existing management." Sam Finkelstein discusses the challenges and opportunities of the ExiClip.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.